Success Metrics

Clinical Success Rate
57.1%

Based on 8 completed trials

Completion Rate
57%(8/14)
Active Trials
11(33%)
Results Posted
125%(10 trials)
Terminated
6(18%)

Phase Distribution

Ph phase_1
2
6%
Ph phase_3
1
3%
Ph phase_2
17
52%
Ph not_applicable
9
27%

Phase Distribution

2

Early Stage

17

Mid Stage

1

Late Stage

Phase Distribution29 total trials
Phase 1Safety & dosage
2(6.9%)
Phase 2Efficacy & side effects
17(58.6%)
Phase 3Large-scale testing
1(3.4%)
N/ANon-phased studies
9(31.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

47.1%

8 of 17 finished

Non-Completion Rate

52.9%

9 ended early

Currently Active

11

trials recruiting

Total Trials

33

all time

Status Distribution
Active(15)
Completed(8)
Terminated(9)
Other(1)

Detailed Status

Completed8
Recruiting7
Terminated6
Active, not recruiting4
Not yet recruiting4
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
33
Active
11
Success Rate
57.1%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (6.9%)
Phase 217 (58.6%)
Phase 31 (3.4%)
N/A9 (31.0%)

Trials by Status

active_not_recruiting412%
recruiting721%
terminated618%
unknown13%
withdrawn39%
not_yet_recruiting412%
completed824%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT07414992Phase 2

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Not Yet Recruiting
NCT05581589Phase 2

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

Terminated
NCT04960709Phase 3

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

Active Not Recruiting
NCT03609216Phase 2

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Active Not Recruiting
NCT07332351Phase 2

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

Not Yet Recruiting
NCT03520491Phase 2

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Active Not Recruiting
NCT07008833Not Applicable

Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer

Not Yet Recruiting
NCT06263153Phase 2

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Recruiting
NCT06091124Phase 2

Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma

Recruiting
NCT07048457Phase 2

Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma

Recruiting
NCT07202819Not Applicable

Effect of Neoadjuvant Chemotherapy on MRI Accuracy Before Cystectomy

Recruiting
NCT04383743Phase 2

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Completed
NCT06184516Phase 2

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

Recruiting
NCT02968732Not Applicable

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

Active Not Recruiting
NCT03806439

Post-surgical Delirium in Patients Undergoing Radical Cystectomy.

Not Yet Recruiting
NCT06170177

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Recruiting
NCT00777491Phase 2

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Completed
NCT02767921Phase 1

sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer

Terminated
NCT04900558

Robotic Radical Cystectomy Outcomes

Recruiting
NCT03977831Not Applicable

Study Comparing Open Radical Cystectomy With Robot-assisted Cystectomy in Patients With Bladder Cancer

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
33